Torrent Pharmaceuticals Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
52.33 | 45.74 | 14.4% | 44.7 | +17.06% |
| P/S |
|
8.21 | 5.12 | 60.16% |
|
|
| P/BV |
|
12.64 | 6.3 | 100.65% |
|
|
| P/FCF |
|
23.19 | 168.72 | -86.26% |
|
|
| Ev/Ebitda |
|
19.65 | 13.54 | 45.14% |
|
|
| Ev/S |
|
8.5 | 4.77 | 78.29% |
|
|
| Ev/FCF |
|
31.69 | 163.7 | -80.64% |
|
|
| E/P |
|
0.0252 | 0.0451 | -44.14% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
27.33 | 20.29 | 34.74% | 28.98 | -5.69% |
| ROE |
|
25.38 | 17.11 | 48.29% |
|
|
| ROA |
|
11.02 | 10.34 | 6.58% |
|
|
| ROIC |
|
19.66 | 10.89 | 80.6% |
|
|
| ROS |
|
15.68 | 11.98 | 30.87% |
|
|
| ROCE |
|
0 | 4.26 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.36 | 1.22 | 11.95% | 1.67 | -18.23% |
| Nеt Debt/Ebitda |
|
1.07 | 1.06 | 1.52% |
|
|
| Debt/Ratio |
|
0.2614 | 0.1307 | 100.02% |
|
|
| Debt/Equity |
|
0.7623 | 0.5488 | 38.9% |
|
|
| Debt/Net Income |
|
2.38 | 3.19 | -25.54% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
3.7/10
|
1.48 | 11.92 | -87.59% | 1.51 | -2.28% |
| Number of years of dividend growth |
|
0 | 1.26 | -100% | ||
| DSI |
|
0.8571 | 0.8503 | 0.8034% |
|
|
| Average dividend growth |
|
11.51 | -63.65 | -118.08% |
|
|
| Average percentage for 5 years |
|
1.51 | 11.6 | -86.94% |
|
|
| Average percentage for payments |
|
49.59 | 30.57 | 62.2% |
|
|
| Difference from average difference in sector |
|
-10.44 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
35.76 | 80.84 | -55.76% | ||
| Growth impulse Ebitda in 5 years |
|
71.8 | 45.31 | 58.46% | ||
| Growth impulse Net Income in 5 years |
|
61.64 | 131.41 | -53.09% | ||
| Growth impulse FCF in 5 years |
|
187.61 | 76.02 | 146.79% | ||
| Growth impulse EPS in 5 years |
|
61.6 | 286.48 | -78.5% |
IP Score
6.21/10
